Bukwang Pharm Cash Flow Reinvestment Rate
Bukwang Pharm cash flow reinvestment rate. Bukwang Pharm (003000) has a Cash Flow Reinvestment Rate of 2.10x as of June 2025, reinvesting ₩21.05 Billion (capex ₩2.80 Billion plus investments ₩-18.25 Billion) from operating cash flow of ₩10.03 Billion. Explore debt repayment capacity of Bukwang Pharm to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Bukwang Pharm (2007–2024)
Cash flow reinvestment rate of Bukwang Pharm from 2007 to 2024. Historical reinvestment intensity for Bukwang Pharm across 10 annual periods. Explore how much does Bukwang Pharm reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Bukwang Pharm Cash Flow Reinvestment Rate by Year (2007–2024)
Bukwang Pharm cash flow reinvestment rate by year from 2007 to 2024. Year-by-year capital reinvestment analysis for Bukwang Pharm. For the full cash flow conversion analysis, see Bukwang Pharm (003000) cash conversion ratio.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.17x | ₩40.11 Billion | ₩34.36 Billion | ₩2.61 Billion | ▲ +136.0% |
| 2022 | 0.49x | ₩8.14 Billion | ₩16.46 Billion | ₩4.99 Billion | ▲ +121.0% |
| 2021 | 0.22x | ₩5.94 Billion | ₩26.52 Billion | ₩785.05 Million | ▼ -96.8% |
| 2020 | 7.09x | ₩5.13 Billion | ₩723.17 Million | ₩1.92 Billion | ▲ +14.4% |
| 2018 | 6.20x | ₩42.27 Billion | ₩6.82 Billion | ₩3.71 Billion | ▲ +830.9% |
| 2017 | 0.67x | ₩5.70 Billion | ₩8.56 Billion | ₩4.49 Billion | ▼ -25.6% |
| 2015 | 0.89x | ₩9.21 Billion | ₩10.30 Billion | ₩4.58 Billion | ▲ +343.3% |
| 2014 | 0.20x | ₩5.62 Billion | ₩27.86 Billion | ₩2.97 Billion | ▼ -76.3% |
| 2013 | 0.85x | ₩31.14 Billion | ₩36.52 Billion | ₩3.74 Billion | ▲ +14.9% |
| 2007 | 0.74x | ₩20.69 Billion | ₩27.87 Billion | ₩20.69 Billion | — |